Skip to main content

Table. 1 Baseline characteristics of study participants

From: Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial

 

Placebo(n = 16)

ET(n = 18)

EPT(n = 17)

Age (years)

56.6 ± 3.8

57.7 ± 6.3

57.5 ± 4.4

Age at menarche (years)

14.8 ± 1.1

14.9 ± 2.4 

15.1 ± 1.7

Type of menopause

   

 Natural

15 (92.7)

16 (88.9)

16 (94.1)

 Surgical

1 (6.3)

2 (11.1)

1 (5.9)

Age at menopause (years)

52.2 ± 2.8

49.8 ± 4.8

51.2 ± 3.9

Duration from menopause (months)

39.6 ± 31.1

62.9 ± 41.4

63.9 ± 61.6

Parity

1.9 ± 0.9

2.1 ± 0.4

2.2 ± 0.5

Body mass index (kg/m2)

23.5 ± 1.7

24.6 ± 2.9

24.9 ± 3.2

Medical history

   

 Diabetes mellitus

1 (6.25)

0 (0.0)

1 (5.9)

 Dyslipidemiaa [statin use]

2 (12.5) [2]

8 (44.4) [3]

2 (11.8) [2]

 Antihypertensive medication use

11 (68.8)

11 (61.1)

8 (47.1)

History of hormone use

   

 Oral contraceptive

2 (12.5)

1 (5.6)

0 (0.0)

 Menopausal hormone therapy

4 (25.0)

7 (38.9)

5 (29.4)

Current smoking

0 (0.0)

1 (5.6)

0 (0.0)

Alcohol consumption

1 (6.3)

3 (16.7)

4 (23.5)

Family history of hypertension

7 (43.8)

13 (72.2)

8 (47.1)

  1. Data are presented as means ± standard deviations or numbers (%)
  2. ET estrogen therapy, EPT estrogen + progestogen therapy
  3. aP-value for between-group differences < 0.05, by Fisher’s exact test